Ixabepilone in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well ixabepilone works in treating patients with relapsed
or refractory aggressive non-Hodgkin's lymphoma. Drugs used in chemotherapy, such as
ixabepilone, work in different ways to stop cancer cells from dividing so they stop growing
or die.